Particle.news

Download on the App Store

Study Ties Menopause to Distinct MS Onset Patterns and Comorbidity Burden

Presented at ECTRIMS 2025, the analysis signals tailored care by life stage, with findings pending peer review.

Overview

  • The conference report analyzed 864 patients from a larger 4,191-person cohort, comparing 298 premenopausal women, 300 postmenopausal women, and 265 age-matched men.
  • Initial symptoms involved the optic nerve more often in premenopausal women at 21.8% than in postmenopausal women at 15% or men at 11.7%.
  • Spinal cord onset was more common in postmenopausal women at 44% and in men at 48.3% compared with 27.5% in premenopausal women.
  • Comorbidities were present in 15.1% of premenopausal women versus 41% of postmenopausal women and 36.6% of men, with cardiovascular disease affecting 24.7% of postmenopausal women and endocrine or metabolic disorders 10.3%.
  • Deaths during follow-up were reported in 15 men and nine postmenopausal women, with none among premenopausal women, and the authors suggested life-stage–specific monitoring and treatment priorities.